VerdePharmHealth Signs Exclusive Partnership Agreement With Greene Street Pharmaceuticals For Cannabidiol Transdermal Patch

VerdePharmHealth announced the signing of an exclusive national group purchasing agreement with Greene Street Pharmaceuticals that will utilize proprietary CBD-Cubed™ transdermal 24-hour delivery technology for multi-specialty individual. Both organizations aim to educate health care provider organizations with best-in-class cannabinoid delivery options, simplify the supply chain, and reduce costs to meet the needs of the health care professionals and consumers.

According to Nikko Khazana, R.Ph., chief commercial officer at VerdePharmHealth, transdermal patches have many advantages over alternative routes of administration and that is why Greene Street Pharmaceuticals established a proprietary transdermal technology patch to expand . . .